Antinuclear Antibody-Positive Ticlopidine-Induced Hepatitis [PDF]
Canadian Journal of Gastroenterology, 1996 Ticlopidine hydrochloride has been shown to reduce the risk of first or recurrent stroke in patients who have experienced a transient ischemic attack, reversible ischemic neurological deficit, recurrent stroke or first stroke. Severe liver dysfunction is
Sander Jo Veldhuyzen van Zanten +1 more
doaj +2 more sources
Ticlopidine in Its Prodrug Form Is a Selective Inhibitor of Human NTPDase1 [PDF]
Mediators of Inflammation, 2014 Nucleoside triphosphate diphosphohydrolase-1 (NTPDase1), like other ectonucleotidases, controls extracellular nucleotide levels and consequently their (patho)physiological responses such as in thrombosis, inflammation, and cancer.
Joanna Lecka +3 more
doaj +2 more sources
Agranulocytosis and hepatic toxicity with ticlopidine therapy: a case report [PDF]
Journal of Medical Case Reports, 2010 Introduction Ticlopidine is a platelet inhibitor used to prevent thrombosis in patients with cerebrovascular or coronary artery disease. The most common side effects are mild and transitory: diarrhea, dyspepsia, nausea and rashes.
Previtera Antonino M, Pagani Rossella
doaj +3 more sources
Ticlopidine-induced cholestatic hepatitis: A case report and review of the literature [PDF]
Italian Journal of Medicine, 2012 Introduction Cholestatic hepatitis is frequently a drug-related syndrome. We describe the case of a 57-year-old man who developed cholestatic hepatitis two months after starting therapy with ticlopidine following a carotid endarterectomy.Materials and ...
Luigi Anastasio +7 more
doaj +3 more sources
AGRANULOCYTOSIS AND MACULOPAPULAR RASH AFTER TREATMENT WITH TICLOPIDINE – CASE REPORT [PDF]
Zdravniški Vestnik, 2003 Background. Ticlopidine is one of inhibitors of platelet aggregation indicated for reducing the risk of thrombotic stroke in patients who have experienced thrombotic stroke, ischemic attacks, unstable angina pectoris, coronary artery stenting and ...
Janja Blatnik +4 more
doaj +2 more sources
Lansoprazole-Induced Microscopic Colitis Mimicking Anticancer Drug-Related Diarrhea During Lenvatinib and Pembrolizumab Combination Therapy: A Case Report. [PDF]
Clin Case RepABSTRACT Persistent diarrhea during anticancer therapy may not be attributable to anticancer agents. Our patient presented with diarrhea during lenvatinib–pembrolizumab therapy, likely caused by lansoprazole‐induced microscopic colitis. Even when symptoms closely resemble anticancer drug or immune‐related colitis, drug‐induced colitis due to ...
Maruyama S +6 more
europepmc +2 more sources
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
, 2022 Hepatology, EarlyView.
Robert J. Fontana +6 more
wiley +1 more source
When Delirium Unmasks a Silent Myocardial Infarction. [PDF]
J Am Geriatr SocAbbreviations: hs‐TnT: high sensitivity Troponin T; STEMI: ST‐elevation myocardial infarction.
Casali E +10 more
europepmc +2 more sources
Kaposiform hemangioendothelioma: Diagnosis and treatment [PDF]
Pediatr InvestigVascular endothelial growth factor‐C (VEGF‐C)/vascular endothelial growth factor receptor‐3 (VEGFR‐3) and angiopoietin‐2 (Ang‐2)/tyrosine kinase with immunoglobulin‐like and EGF‐like domain 2 (TIE2) signaling pathways play an important role in lymphangiogenesis.
Tian Y, Tian Y, Wei L, Xu Z, Li L, Ma L.
europepmc +2 more sources
Clinical pharmacokinetics of ticlopidine [PDF]
, 1994 Platelets contribute significantly to arterial-occlusive thrombosis, one of the major causes of death and disease throughout the world. Consequently, inhibiting platelet function is a potentially important therapeutic goal.
Desager, Jean-Pierre
core +1 more source